glp-1 supply news today Trying to save money on weight-loss drugs? Several brand-name #GLP-1 #WeightLossDrugs are FDA-approved—but many LESS EXPENSIVE unapproved versions are being sold online and can be dangerous. A man who injected #retatrutide—a GLP-1 launches inject over 2x

Host defense peptides as a new drug lead to a strategy for inflammatory bowel disease

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a protective protein found naturally in human gastric juice

Strategies designed to regulate the carnitine pool have shown great potential and prospects in the treatment of metabolic diseases, cardiovascular diseases and neurodegenerative diseases

Over the past decade, regulators started approving them as treatments for weight loss first as liraglutide, sold under the brand Saxenda and, more recently, in the form of semaglutide or tirzepatide, under brands like Wegovy and Zepbound

Asia and Pacific Journal of Clinical Nutrition